Original Investigation
Effect of Nebulized Hypertonic Saline on Acute Bronchiolitis Hospitalization
François Angoulvant, MD, PhD; Xavier Bellêttre, MD; Karen Milcent, MD, PhD; Jean-Paul Teglas, PhD; Isabelle Claudet, MD, MSc; Christèle Gras Le Guen, MD, PhD; Loïc de Pontual, MD, PhD; Philippe Minodier, MD, MSc; François Dubos, MD, PhD; Jacques Brouard, MD, PhD; Valérie Soussan-Banini, MD; Vanessa Degas-Bussiere, MD; Amélie Gatin, MD; Cyril Schweitzer, MD, PhD; Ralph Epaud, MD, PhD; Amélie Ryckewaert, MD, MSc; Pierrick Cros, MD; Yves Marot, MD; Philippe Flahaut, MD; Pascal Saunier, MD; Philippe Babe, MD; Géraldine Patteau, MD; Mathilde Delebarre, MD, PhD; Luigi Titomanlio, MD, PhD; Bénédicte Vrignaud, MD; Thanh-Van Trieu, MD; Abdelilah Tahir, MD; Delphine Regnard, MD; Pascale Micheau, MD; Oussama Charara, MD; Simon Henry, MD; Dominique Ploin, MD, PhD; Henri Panjo, MSc; Astrid Vabret, MD, PhD; Jean Bouyer, PhD; Vincent Gajdos, MD, PhD; for the Efficacy of 3% Hypertonic Saline in Acute Viral Bronchiolitis (GUERANDE) Study Group
JAMA Pediatrics